| 1 |
Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches |
|
|
| Murugan Prasathkumar, Robert Becky, Salim Anisha, Chenthamara Dhrisya, Subramaniam Sadhasivam |
|
| Biotechnology Letters. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Redoxisome and Diabetic Retinopathy: Pathophysiology and Therapeutic Interventions |
|
|
| Isha Sharma, Karan Singh Yadav, Madhav Nilakanth Mugale |
|
| Pharmacological Research. 2022; : 106292 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Gallic acid and myricetin-rich
Labisia pumila
extract mitigated multiple diabetic eye disorders in rats
|
|
|
| Nazmun Nahar, Suhaila Mohamed, Noordin Mohamed Mustapha, Lau Seng Fong, Nur Iliyani Mohd Ishak |
|
| Journal of Food Biochemistry. 2021; 45(11) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema–Systematic review, meta-analysis and meta-regression |
|
|
| Mohamed Abdel-Maboud, Esraa Menshawy, Eshak I. Bahbah, Oumaima Outani, Amr Menshawy, Demetrios G. Vavvas |
|
| PLOS ONE. 2021; 16(1): e0245010 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Cellular targets in diabetic retinopathy therapy |
|
|
| María Lucía Rodríguez, Iván Millán, Ángel Luis Ortega |
|
| World Journal of Diabetes. 2021; 12(9): 1442 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy |
|
|
| Giuliana Ribeiro de Carvalho, Vagner Loduca Lima, Glaucia Luciano da Veiga, Fernando Adami, Beatriz da Costa Aguiar Alves, Edimar Cristiano Pereira, David Feder, Fernando Luiz Affonso Fonseca |
|
| Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 3149 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Diabetic Retinopathy and Ocular Melanoma: How Far We Are? |
|
|
| Eliana B. Souto, Joana R. Campos, Raquel Da Ana, Joana F. Fangueiro, Carlos Martins-Gomes, Alessandra Durazzo, Massimo Lucarini, Elena Sánchez López, Marta Espina, Maria Luisa García, Amélia M. Silva, Fernando Mendonça, Antonello Santini, Selma B. Souto |
|
| Applied Sciences. 2020; 10(8): 2777 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Quercetin attenuates high glucose-induced injury in human retinal pigment epithelial cell line ARPE-19 by up-regulation of miR-29b |
|
|
| Xuejiao Wang, Hui Li, Hao Wang, Jingyun Shi |
|
| The Journal of Biochemistry. 2020; 167(5): 495 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
The protective effects of lycopus lucidus turcz in diabetic retinopathy and its possible mechanisms |
|
|
| Jinlu Liu, Sai Bhuvanagiri, Xiaohan Qu |
|
| Artificial Cells, Nanomedicine, and Biotechnology. 2019; 47(1): 2900 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation |
|
|
| Choon-Soo Lee, Yun Gi Kim, Hyun-Jai Cho, Jonghanne Park, Heewon Jeong, Sang-Eun Lee, Seung-Pyo Lee, Hyun-Jae Kang, Hyo-Soo Kim |
|
| Scientific Reports. 2016; 6(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation |
|
|
| Zengyang Yu,Bin Lu,Yuchen Sheng,Lingyu Zhou,Lili Ji,Zhengtao Wang |
|
| Biochimica et Biophysica Acta (BBA) - General Subjects. 2015; 1850(4): 824 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Identifying and interpreting novel targets that address more than one diabetic complication: a strategy for optimal end organ protection in diabetes |
|
|
| Shinji Hagiwara,Jay C. Jha,Mark E. Cooper |
|
| Diabetology International. 2014; 5(1): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism |
|
|
| Chen-Yuan Gong,Zeng-Yang Yu,Bin Lu,Li Yang,Yu-Chen Sheng,Yuan-Min Fan,Li-Li Ji,Zheng-Tao Wang |
|
| Vascular Pharmacology. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Identifying and interpreting novel targets that address more than one diabetic complication: A strategy for optimal end organ protection in diabetes |
|
|
| Hagiwara, S., Jha, J.C., Cooper, M.E. |
|
| Diabetology International. 2014; 5(1): 1-20 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
Antihyperglycemic action of rhodiola-aqeous extract in type1-like diabetic rats |
|
|
| Niu, C.-S., Chen, L.-J., Niu, H.-S. |
|
| BMC Complementary and Alternative Medicine. 2014; 14: 20 |
|
| [Pubmed] [Google Scholar] |
|
| 16 |
In vitro and ex vivo retina angiogenesis assays |
|
|
| Sara Rezzola,Mirella Belleri,Giuseppina Gariano,Domenico Ribatti,Ciro Costagliola,Francesco Semeraro,Marco Presta |
|
| Angiogenesis. 2014; 17(3): 429 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Neuropeptides and diabetic retinopathy |
|
|
| Robert Gábriel |
|
| British Journal of Clinical Pharmacology. 2013; 75(5): 1189 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Inflammation and Pharmacological Treatment in Diabetic Retinopathy |
|
|
| Snježana Kaštelan,Martina Tomic,Antonela Gverovic Antunica,Jasminka Salopek Rabatic,Spomenka Ljubic |
|
| Mediators of Inflammation. 2013; 2013: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Diabetes, obesity and vascular disease - An update |
|
|
| Papanas, N. and Katsiki, N. and Putz, Z. and Mikhailidis, D.P. |
|
| Current Pharmaceutical Design. 2013; 19(27): 4900-4903 |
|
| [Pubmed] [Google Scholar] |
|
| 20 |
Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox |
|
|
| Costa, P.Z. and Soares, R. |
|
| Life Sciences. 2013; 92(22): 1037-1045 |
|
| [Pubmed] [Google Scholar] |
|
| 21 |
Neuropeptides and diabetic retinopathy |
|
|
| Gábriel, R. |
|
| British Journal of Clinical Pharmacology. 2013; 75(5): 1189-1201 |
|
| [Pubmed] [Google Scholar] |
|
| 22 |
Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application |
|
|
| Pollinger, K. and Hennig, R. and Ohlmann, A. and Fuchshofer, R. and Wenzel, R. and Breunig, M. and Tessmar, J. and Tamm, E.R. and Goepferich, A. |
|
| Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(15): 6115-6120 |
|
| [Pubmed] [Google Scholar] |
|
| 23 |
Inflammation and pharmacological treatment in diabetic retinopathy |
|
|
| Kaštelan, S., Tomić, M., Gverović Antunica, A., Salopek Rabatić, J., Ljubić, S. |
|
| Mediators of Inflammation. 2013; 2013 |
|
| [Pubmed] [Google Scholar] |
|
| 24 |
Nowe aspekty farmakoterapii retinopatiicukrzycowej u chorych na cukrzyce typu 2 | [New aspects of pharmacological treatment of diabetic retinopathyin type 2 diabetic patients] |
|
|
| Milczarczyk, A., Franek, E. |
|
| Kardiologia Polska. 2013; 71(2): 21-26 |
|
| [Pubmed] [Google Scholar] |
|
| 25 |
Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: A meta-analysis |
|
|
| Zhang, X.-L., Chen, J., Zhang, R.-J., Zhou, Q., Qin, X.-Y. |
|
| International Journal of Ophthalmology. 2013; 6(4): 546-552 |
|
| [Pubmed] [Google Scholar] |
|
| 26 |
Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application |
|
|
| Klaus Pollinger, Robert Hennig, Andreas Ohlmann, Rudolf Fuchshofer, Rebecca Wenzel, Miriam Breunig, Joerg Tessmar, Ernst R. Tamm, Achim Goepferich |
|
| Proceedings of the National Academy of Sciences. 2013; 110(15): 6115 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox |
|
|
| Paulo Zoé Costa,Raquel Soares |
|
| Life Sciences. 2013; 92(22): 1037 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
